6'-amino-5,9'-dinitro-2-oxo-1',2',3',4'-tetrahydrospiro[indoline-3,8'-pyrido[1,2-a]pyrimidine]-7'-carbonitrile

ID: ALA3765697

Chembl Id: CHEMBL3765697

PubChem CID: 127025348

Max Phase: Preclinical

Molecular Formula: C16H13N7O5

Molecular Weight: 383.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CC1=C(N)N2CCCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccc([N+](=O)[O-])cc12

Standard InChI:  InChI=1S/C16H13N7O5/c17-7-10-13(18)21-5-1-4-19-14(21)12(23(27)28)16(10)9-6-8(22(25)26)2-3-11(9)20-15(16)24/h2-3,6,19H,1,4-5,18H2,(H,20,24)

Standard InChI Key:  GINLDVRWRYODAL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3765697

    ---

Associated Targets(Human)

BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.32Molecular Weight (Monoisotopic): 383.0978AlogP: 0.23#Rotatable Bonds: 2
Polar Surface Area: 180.46Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.83CX Basic pKa: 0.20CX LogP: -0.01CX LogD: -0.01
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.48Np Likeness Score: -0.93

References

1. Maryamabadi A, Hasaninejad A, Nowrouzi N, Mohebbi G, Asghari B..  (2016)  Application of PEG-400 as a green biodegradable polymeric medium for the catalyst-free synthesis of spiro-dihydropyridines and their use as acetyl and butyrylcholinesterase inhibitors.,  24  (6): [PMID:26879857] [10.1016/j.bmc.2016.02.019]

Source